Overview
Tobias Wertheimer practices in Regensburg, Germany. Mr. Wertheimer is highly rated in 3 conditions, according to our data. His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Chronic Graft Versus Host Disease (cGvHD), Prolymphocytic Leukemia, Graft Versus Host Disease (GvHD), and Prostatic Artery Embolization.
His clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)Mr. Wertheimer isAdvanced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Chronic T-Cell Leukemia (CTCL)Mr. Wertheimer isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Prolymphocytic LeukemiaMr. Wertheimer isAdvanced. Learn about Prolymphocytic Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Wertheimer isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaMr. Wertheimer isExperienced. Learn about Adult T-Cell Leukemia.
- Bronchiolitis ObliteransMr. Wertheimer isExperienced. Learn about Bronchiolitis Obliterans.
- Graft Versus Host Disease (GvHD)Mr. Wertheimer isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaMr. Wertheimer isExperienced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Mr. Wertheimer isExperienced. Learn about Mantle Cell Lymphoma (MCL).